CD19 and diffuse large B-cell lymphoma: In June 2020, Lefebvre et al. reported a retrospective study of the effects of CD19 CAR T-cell therapy on cardiac function in 145 adult patients with DLBCL (30%), ALL (25%), or CLL (45%).